BioSpace News Archive

On Demand Pharmaceuticals, Inc., an innovative technology company transforming the way medicines are made, announced that it has signed a Preferred Supplier agreement with Azzur Group through 2024.

Bayer, one of the country’s leading life-sciences companies, announced two changes to its U.S. Country Leadership Team.

Oxurion NV a biopharmaceutical company developing next generation standard of care ophthalmic therapies, with clinical stage assets in vascular retinal disorders, announced that Michael Dillen, Chief Business Officer, will participate in two investor conferences in June.

Elucida Oncology, a clinical-stage biotechnology company developing the next frontier in targeted cancer therapy, announced today the Company will present a Trials in Progress poster presentation for the Phase 1/2 Study of ELU001 in patients with advanced, recurrent, or refractory cancers overexpressing Folate-Receptor Alpha (FRα), at the American Society of Clinical Oncology (ASCO) Annual Meeting.

Forcyte Biotechnologies, a tech-enabled drug discovery company targeting diseases of mechanobiology, has secured new funding from Milestone View, Pioneer Fund, Acequia Capital, Y Combinator, Jude Gomila, and others.

The global active pharmaceutical ingredients market size is expected to reach around US$ 328 billion by 2030 from valued at US$ 169 bn in 2020, growing at a CAGR of 6.1% from 2021 to 2030.

According to Vision Research Reports, the cell and gene therapy clinical trials market size is expected to be worth around US$ 48.4 billion by 2030 and is predicted to grow at a CAGR of 24.3% from 2021 to 2030.

According to Vision Research Reports, the clinical trials market size is predicted to reach around US$ 75 billion by 2030 and expanding growth at a CAGR of 6% during forecast period 2022 to 2030.

According to Vision Research Reports, the digital therapeutics market size is expected to be worth around US$ 29.1 billion by 2030 and is projected to grow at a CAGR of 33.1% during forecast period 2021 to 2030.

According to Vision Research Reports, the endoscopy devices market size is expected to reach around US$ 72.9 billion by 2030 and is projected to grow at a remarkable CAGR of 9.3% from 2021 to 2030.